Hui-Ching Hsu
Overview
Explore the profile of Hui-Ching Hsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen W, Lin T, Chang Y, Shen Y, Hsu H, Kuo T, et al.
Clin Transl Sci
. 2025 Mar;
18(3):e70177.
PMID: 40075548
The risk of psoriasis in diabetic patients has rarely been explored. This study aims to compare the risk of incident psoriasis in patients with Type 2 diabetes (T2D) who initiate...
2.
Lee Y, Kuo Y, Chuang B, Hsu H, Huang Y, Su Y, et al.
Zoological Lett
. 2024 Apr;
10(1):9.
PMID: 38689320
Multiple mating by avian females may increase hatching and overall brood success; however, reproductive effort and parental investment are costly, and females may be gradually depleted, with lowered outputs over...
3.
Juang Y, Tsai J, Gu W, Hsu H, Lin C, Wu C, et al.
J Med Chem
. 2024 Feb;
67(5):3626-3642.
PMID: 38381886
In this study, a series of 2- and/or 3-substituted juglone derivatives were designed and synthesized. Among them, , , , , and showed stronger inhibition activity against cell surface PDI...
4.
Ho Y, Hsu H, Wu B, Lin Y, Liao L, Yeh C
J Control Release
. 2023 Mar;
356:481-492.
PMID: 36921723
Ischemia-reperfusion (I/R) injury is a pathological process that causes vascular damage and dysfunction which increases recurrence and/or mortality in myocardial infarction, ischemic stroke, and organ transplantation. We hypothesized that ultrasound-stimulated...
5.
Lin T, Hsu H, Shen Y, Chang Y, Chen W, Lee H, et al.
Allergy
. 2022 Nov;
78(6):1663-1665.
PMID: 36412075
No abstract available.
6.
Chou S, Yeh H, Lin T, Chang Y, Hsu H, Shen Y, et al.
Front Immunol
. 2022 Oct;
13:992819.
PMID: 36275719
Background: Interferon in combination with ribavirin has been the standard of care for chronic hepatitis C virus infection (HCV) for the past few decades. However, its effect on the risk...
7.
Lin Y, Li Y, Hsu H, Tsai J, Lee J, Tai C, et al.
Biochem Pharmacol
. 2022 Jun;
202:115152.
PMID: 35752281
There is growing evidence of the importance of protease-activated receptor 4 (PAR4), one of thrombin receptors, as a therapeutic target in thrombotic cardiovascular diseases. In the present study, we utilized...
8.
Shen Y, Hsu H, Lin T, Chang Y, Hu L, Chen L, et al.
J Clin Oncol
. 2022 Jan;
40(11):1206-1219.
PMID: 35044851
Purpose: H1-antihistamines (AHs) may exert protective effects against cancer. This study investigated the association of AH use with the risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus...
9.
Ho Y, Hsu H, Kang S, Fan C, Chang C, Yeh C
ACS Appl Bio Mater
. 2022 Jan;
3(4):1968-1975.
PMID: 35025319
Transdermal delivery systems provide a convenient noninvasive approach for drug administration through the skin, and they have been widely developed for in-home health care. The stratum corneum of the skin...
10.
Lin S, Chang Y, Lin T, Hu L, Hou T, Hsu H, et al.
Front Immunol
. 2021 Oct;
12:736036.
PMID: 34659225
Background: Previous study revealed proton pump inhibitors (PPIs) have an effect on gut microbiota. Alteration of the microbiome causes changes of the host immune system and then induces the development...